Family Medicine Doctors in Cave Creek, AZ Accepting Medicare

7 Family Medicine doctors found. Showing 1 - 7

Dr. Mark A Ballard, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7108 E Highland Rd, Cave Creek, AZ 85331 Phone: 480-391-3744    Fax: 480-391-2867

Dr. Jerome E Rubbelke Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4712 E Dynamite Blvd, Cave Creek, AZ 85331 Phone: 480-342-8711    Fax: 480-342-7077

Scott C. Waters, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4712 E Dynamite Blvd, Cave Creek, AZ 85331 Phone: 480-342-8711    Fax: 480-342-7077

Silvia Guerrero, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 29455 N Cave Creek Rd Ste 605, Cave Creek, AZ 85331 Phone: 602-996-5595    Fax: 602-996-5610

Dr. Justin W Wight, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4712 E Dynamite Blvd, Cave Creek, AZ 85331 Phone: 480-342-8711    Fax: 480-342-7077

Kim L Miller, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4712 E Dynamite Blvd, Cave Creek, AZ 85331 Phone: 480-342-8711    Fax: 480-342-7077

Dr. C. Daniel Murphy, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4712 E Dynamite Blvd, Cave Creek, AZ 85331 Phone: 480-342-8711    Fax: 480-342-7077

News Archive

Immunomedics 2010 fourth quarter revenue decreases to $0.7 million

Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.

Carriage Services announces "Company & Investment Profile" update

Carriage Services, Inc. today announced that it has updated its "Company & Investment Profile,".Carriage's updated Company & Investment Profile includes updated discussions of Carriage's business, operating and growth strategies, historical financial information, financial outlook and more.

FDA grants orphan drug designation to ERYTECH's lead product for AML treatment

ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.

Heart OMics in AGEing project receives European Commission grant

The HOMAGE (Heart OMics in AGEing) project, coordinated by the French National Institute of Health and Medical Research (INSERM), has been awarded a grant by the European Commission for a 6 year period.

New Australian chlamydia trial

General practitioners are being recruited for a world-first trial which University of Melbourne researchers hope will triple chlamydia testing rates among participating clinics.

Read more Medical News

› Verified 7 days ago